Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes.
Mathilde NativelFabrice SchneiderPierre-Jean SaulnierElise GandStéphanie RagotOlivier MeilhacPhilippe RondeauElena BurilloMaxime CournotLouis PotierGilberto VelhoMichel MarreRonan RousselVincent RigalleauKamel MohammediSamy HadjadjPublished in: Diabetes care (2018)
Independent associations exist between high plasma TNFR1 or IMA concentrations and increased 5.6-year risk of major LEAD in people with type 2 diabetes. TNFR1 allows incremental prognostic information, suggesting its use as a biomarker for LEAD.
Keyphrases